| Quinoxaline Basic information |
| Product Name: | Quinoxaline |
| Synonyms: | 1,4-Benxodiazine;1,4-Naphthyridine;Phenopiazine;Phenpiazine;Quinazine;USAF EK-7094;usafek-7094;QUINOXALINE |
| CAS: | 91-19-0 |
| MF: | C8H6N2 |
| MW: | 130.15 |
| EINECS: | 202-047-4 |
| Product Categories: | Building Blocks;Chemical Synthesis;Quinolines, Quinazolines and derivatives;Benzenes;Heterocyclic Building Blocks;Quinoxalines;Heterocyclic Compounds |
| Mol File: | 91-19-0.mol |
 |
| Quinoxaline Chemical Properties |
| Melting point | 29-32 °C (lit.) |
| Boiling point | 220-223 °C (lit.) |
| density | 1.124 g/mL at 25 °C (lit.) |
| refractive index | nD48 1.6231 |
| Fp | 209 °F |
| storage temp. | 2-8°C |
| solubility | alcohol: freely soluble(lit.) |
| pka | 0.56(at 20℃) |
| form | Crystalline Low Melting Solid |
| color | Light yellow to brown |
| Water Solubility | SOLUBLE |
| Merck | 14,8078 |
| BRN | 109351 |
| Stability: | Light Sensitive |
| LogP | 1.320 |
| CAS DataBase Reference | 91-19-0(CAS DataBase Reference) |
| NIST Chemistry Reference | Quinoxaline(91-19-0) |
| EPA Substance Registry System | Quinoxaline (91-19-0) |
| Safety Information |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38-36/38 |
| Safety Statements | 26-36-37/39 |
| WGK Germany | 3 |
| RTECS | VD1225000 |
| Hazard Note | Irritant |
| TSCA | Yes |
| HS Code | 29339990 |
| Provider | Language |
|---|---|
| Quinoxaline | English |
| SigmaAldrich | English |
| ACROS | English |
| ALFA | English |
| Quinoxaline Usage And Synthesis |
| Chemical Properties | light yellow to brown crystalline |
| Uses | Organic synthesis. |
| Uses | Quinoxaline is a reagent used in the synthesis of quinoxaline diimides as small molecule non-fullerene acceptors for organic solar cells. |
| Definition | ChEBI: A naphthyridine in which the nitrogens are at positions 1 and 4. |
| Synthesis Reference(s) | Journal of the American Chemical Society, 69, p. 795, 1947 DOI: 10.1021/ja01196a015 The Journal of Organic Chemistry, 55, p. 1744, 1990 DOI: 10.1021/jo00293a014 Organic Syntheses, Coll. Vol. 4, p. 824, 1963 |
| General Description | Transition metal-free acylation of quinoxaline derivatives, by cross dehydrogenative coupling (CDC) reaction, were studied. |
| Purification Methods | Crystallise quinoxaline from pet ether. It crystallises as the monohydrate on addition of water to a pet ether solution. It has UV: at 242 and 331nm (Ho –2); 234 and 316nm (pH 7.1). The picrate has m 161-162o.[Albert & Phillips J Chem Soc 1294 1956, Beilstein 23 H 176, 23 II 177, 23 III/IV 1226, 23/7 V 135.] |
| Quinoxaline Preparation Products And Raw materials |
